EGR1 and atherosclerosis: In detail, the decrease in MAPK6 expression promotes the interaction between EGR1 and NF‐κB and ultimately accelerates the accumulation of NF‐κB in the nucleus, which promotes the transcription of CXCL12, thereby accelerating the progression of atherosclerosis.